** Belgian property investor Cofinimmo COFB.BR is up
nearly 3% on Thursday, hitting the highest price level since
March 2020, after Barclays' double upgrade to "overweight" from
"underweight"
** The brokerage ups its PT on the stock to EUR 148 what
implies about a 5% upside to the current price
** Barclays sees Cofinimmo as a solid prospect in a
resilient market and finds the company's portfolio positioning
both interesting and attractive
** According to the broker, the company's healthcare
portfolio in particular is relatively defensive whilst
healthcare and office subsidiarisation are the company's main
growth drivers
** Barclays, which also downgraded German competitor Alstria
AOXG.DE post strong share performance, says it prefers
Cofinimmo
** Out of 13 analysts who cover the stock, ten rate it
"buy" and rate three it "hold"
(Reporting by Lucinda Langlands-Perry)
((Lucinda.Langlands-Perry@thomsonreuters.com))